DE2830442C2 - - Google Patents

Info

Publication number
DE2830442C2
DE2830442C2 DE2830442A DE2830442A DE2830442C2 DE 2830442 C2 DE2830442 C2 DE 2830442C2 DE 2830442 A DE2830442 A DE 2830442A DE 2830442 A DE2830442 A DE 2830442A DE 2830442 C2 DE2830442 C2 DE 2830442C2
Authority
DE
Germany
Prior art keywords
lys
ile
cys
peptide
ddz
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE2830442A
Other languages
German (de)
English (en)
Other versions
DE2830442A1 (de
Inventor
Christian Priv. Doz. Dr. 6906 Leimen De Birr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIRR, CHRISTIAN, PROF. DR., 6900 HEIDELBERG, DE
Original Assignee
ORPEGEN MEDIZINISCH-MOLEKULARBIOLOGISCHE FORSCHUNGSGESELLSCHAFT MBH 6900 HEIDELBERG DE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ORPEGEN MEDIZINISCH-MOLEKULARBIOLOGISCHE FORSCHUNGSGESELLSCHAFT MBH 6900 HEIDELBERG DE filed Critical ORPEGEN MEDIZINISCH-MOLEKULARBIOLOGISCHE FORSCHUNGSGESELLSCHAFT MBH 6900 HEIDELBERG DE
Priority to DE19782830442 priority Critical patent/DE2830442A1/de
Priority to CH309879A priority patent/CH637629A5/de
Priority to US06/039,979 priority patent/US4290943A/en
Publication of DE2830442A1 publication Critical patent/DE2830442A1/de
Application granted granted Critical
Publication of DE2830442C2 publication Critical patent/DE2830442C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/042—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers characterised by the nature of the carrier
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
DE19782830442 1978-07-11 1978-07-11 Verfahren zur herstellung von polypeptiden Granted DE2830442A1 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DE19782830442 DE2830442A1 (de) 1978-07-11 1978-07-11 Verfahren zur herstellung von polypeptiden
CH309879A CH637629A5 (de) 1978-07-11 1979-04-03 Verfahren zur herstellung von polypeptiden.
US06/039,979 US4290943A (en) 1978-07-11 1979-05-17 Method of preparing polypeptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782830442 DE2830442A1 (de) 1978-07-11 1978-07-11 Verfahren zur herstellung von polypeptiden

Publications (2)

Publication Number Publication Date
DE2830442A1 DE2830442A1 (de) 1980-01-24
DE2830442C2 true DE2830442C2 (US07655688-20100202-C00010.png) 1992-07-09

Family

ID=6044088

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19782830442 Granted DE2830442A1 (de) 1978-07-11 1978-07-11 Verfahren zur herstellung von polypeptiden

Country Status (3)

Country Link
US (1) US4290943A (US07655688-20100202-C00010.png)
CH (1) CH637629A5 (US07655688-20100202-C00010.png)
DE (1) DE2830442A1 (US07655688-20100202-C00010.png)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2919592A1 (de) * 1979-05-15 1981-01-15 Max Planck Gesellschaft Verfahren zur herstellung von thymosin- alpha 1 und derivaten davon
US4543252A (en) * 1982-01-21 1985-09-24 The Regents Of The University Of California Cationic oligopeptides having microbicidal activity
IT1155060B (it) * 1982-09-02 1987-01-21 Sirac Srl Procedimento per la preparazione di esteri alchilici della alfa-l-aspartil-l-fenilalanina
GB2187461A (en) * 1986-02-03 1987-09-09 Medical Res Council Monitoring method for the synthesis of a linear of amino acid residues
US6107459A (en) * 1991-02-08 2000-08-22 Diatide, Inc. Technetium-99m labeled peptides for diagnostic imaging
US6407059B1 (en) * 1994-06-08 2002-06-18 Peptor Limited Conformationally constrained backbone cyclized peptide analogs
EP1468013A4 (en) * 2002-01-03 2005-03-16 Yissum Res Dev Co CYCLIC PEPTIDES WITH CARBON SKELETON HAVING RESTRICTED CONFORMATION
ATE501164T1 (de) * 2003-07-04 2011-03-15 Lonza Ag Verbessertes verfahren für festphasensynthese

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4028315A (en) * 1970-10-16 1977-06-07 E. R. Squibb & Sons, Inc. Solid phase synthesis of peptides
US3715190A (en) * 1971-09-23 1973-02-06 Univ Sherbrooke System for the solid-phase peptide synthesis
SE399880B (sv) * 1973-05-24 1978-03-06 Ciba Geigy Ag Sett att framstella peptider, som innehaller mer en en disulfidbindning
US4062746A (en) * 1975-05-07 1977-12-13 Wisconsin Alumni Research Foundation Solid phase synthesis of protected peptides
US4093609A (en) * 1976-12-10 1978-06-06 American Home Products Corporation Somatostatin synthesis

Also Published As

Publication number Publication date
CH637629A5 (de) 1983-08-15
DE2830442A1 (de) 1980-01-24
US4290943A (en) 1981-09-22

Similar Documents

Publication Publication Date Title
EP0028627B1 (de) Verfahren zur herstellung von thymosin-alpha1 und derivaten davon
DE2540780C2 (US07655688-20100202-C00010.png)
DE2647843A1 (de) Neue peptide, ihre herstellung sowie verfahren zur herstellung cyclischer peptide
DE69003595T2 (de) Mikroproteine, Verfahren zur Herstellung derselben und Anwendung dieser Mikroproteine als Arzneimittel.
EP0021169B1 (de) Verfahren zur selektiven Bildung von Disulfidbrücken in Polypeptiden und die dabei erhaltenen Produkte als Wirkstoffe enthaltende Arzneimittel
DE3177306T2 (de) Verfahren und Verbindungen zur Herstellung von H-ARG-X-Z-Y-TYR-R.
DE2830442C2 (US07655688-20100202-C00010.png)
DE68911498T2 (de) Polypeptide, isoliert aus dem Gift von Hololena curta.
DE2702699A1 (de) Neue peptidderivate und verfahren zur messung der collagenaseaktivitaet unter verwendung dieser verbindungen
EP0179332B1 (de) Neue ZNS-aktive Peptide mit Wirkung auf das cholinerge System
DE2804566C2 (de) Arginyl-Lysyl-Aspartyl-Valyl-Tyrosin und dessen Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE2505712A1 (de) Traegergebundene sowie biologisch aktive peptide und herstellungsverfahren dafuer
EP0003028B1 (de) Beta h-Endorphin-Analoge, diese enthaltende Präparate und deren Herstellung
DE2727847A1 (de) Polypeptide, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zubereitungen
EP0475184A1 (de) Verfahren zur Herstellung von Peptiden mittels Festphasensynthese
DE2559299A1 (de) Verbindung mit peptidkette zur regulierung der glykaemie, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
CH645880A5 (de) Synthetisches antigenaktives polypeptid, verfahren zu dessen herstellung und das polypeptid enthaltendes antigenes mittel sowie arzneimittel.
DE2324239A1 (de) Verfahren zur herstellung von asparaginylgruppen enthaltenden biologisch aktiven polypeptiden
DE2703121A1 (de) Synthetische pentapeptide und sie enthaltende arzneimittel
DE2447805C2 (de) Verfahren zur Herstellung von Pyroglutamyl-histidyl-prolinamid (TRH)
DE3803545A1 (de) Allylische seitenketten enthaltendes festphasensystem, verfahren zu seiner herstellung und seine verwendung in festphasenreaktionen
DE2807403C2 (US07655688-20100202-C00010.png)
DE1941511C2 (de) Calcitonin-Analoga und ihre α-Desamino- und N↑α↑-Acylaminoderivate, diese Peptide enthaltende pharmazeutische Präparate, und synthetische Verfahren zu ihrer Herstellung sowie zur Herstellung von Calcitonin M
DE2703844A1 (de) Peptide und ihre herstellung
DE2635930A1 (de) Traegergebundene peptide, acth-peptidzwischenprodukte sowie ihre herstellung

Legal Events

Date Code Title Description
8127 New person/name/address of the applicant

Owner name: BIRR, CHRISTIAN, PROF. DR., 6900 HEIDELBERG, DE

8127 New person/name/address of the applicant

Owner name: ORGANOGEN MEDIZINISCH-MOLEKULARBIOLOGISCHE FORSCHU

8110 Request for examination paragraph 44
8127 New person/name/address of the applicant

Owner name: ORPEGEN MEDIZINISCH-MOLEKULARBIOLOGISCHE FORSCHUNG

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee